ZA734876B - Enzymatic salt,the process for its preparation and therapeutical compositions which contain it - Google Patents

Enzymatic salt,the process for its preparation and therapeutical compositions which contain it

Info

Publication number
ZA734876B
ZA734876B ZA734876A ZA734876A ZA734876B ZA 734876 B ZA734876 B ZA 734876B ZA 734876 A ZA734876 A ZA 734876A ZA 734876 A ZA734876 A ZA 734876A ZA 734876 B ZA734876 B ZA 734876B
Authority
ZA
South Africa
Prior art keywords
enzymatic
salt
contain
preparation
therapeutical compositions
Prior art date
Application number
ZA734876A
Other languages
English (en)
Inventor
A Fiecchi
Original Assignee
Errekappa Euroterapici Sas
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Errekappa Euroterapici Sas filed Critical Errekappa Euroterapici Sas
Publication of ZA734876B publication Critical patent/ZA734876B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/16—Purine radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P19/00—Preparation of compounds containing saccharide radicals
    • C12P19/26—Preparation of nitrogen-containing carbohydrates
    • C12P19/28—N-glycosides
    • C12P19/38—Nucleosides
    • C12P19/40—Nucleosides having a condensed ring system containing a six-membered ring having two nitrogen atoms in the same ring, e.g. purine nucleosides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Diabetes (AREA)
  • Pain & Pain Management (AREA)
  • Neurosurgery (AREA)
  • Obesity (AREA)
  • General Engineering & Computer Science (AREA)
  • Psychiatry (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Hematology (AREA)
  • Microbiology (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
ZA734876A 1972-08-02 1973-07-17 Enzymatic salt,the process for its preparation and therapeutical compositions which contain it ZA734876B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT2779372 1972-08-02

Publications (1)

Publication Number Publication Date
ZA734876B true ZA734876B (en) 1974-06-26

Family

ID=11222342

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA734876A ZA734876B (en) 1972-08-02 1973-07-17 Enzymatic salt,the process for its preparation and therapeutical compositions which contain it

Country Status (29)

Country Link
US (1) US3893999A (ro)
JP (1) JPS5235726B2 (ro)
AR (1) AR195350A1 (ro)
AT (1) AT341684B (ro)
AU (1) AU474015B2 (ro)
BE (1) BE802981A (ro)
CA (1) CA1006872A (ro)
CH (1) CH592112A5 (ro)
CS (1) CS195254B2 (ro)
DD (1) DD107461A5 (ro)
DE (1) DE2336401C3 (ro)
DK (1) DK131868C (ro)
ES (1) ES417377A1 (ro)
FI (1) FI52466C (ro)
FR (1) FR2194425B1 (ro)
GB (1) GB1425384A (ro)
HK (1) HK31580A (ro)
HU (1) HU167266B (ro)
IE (1) IE37913B1 (ro)
IL (1) IL42764A (ro)
MX (1) MX4544E (ro)
NL (1) NL152864B (ro)
NO (1) NO137941C (ro)
PL (1) PL87381B1 (ro)
RO (1) RO63451A (ro)
SE (1) SE400085B (ro)
SU (1) SU646915A3 (ro)
YU (1) YU36037B (ro)
ZA (1) ZA734876B (ro)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE39517B1 (en) * 1973-06-27 1978-10-25 Bioresearch Sas Double salts of s-adenosyl-l-methhionine
AR221676A1 (es) * 1974-07-12 1981-03-13 Bioresearch Sas Procedimiento para la preparacion de sales estables sulfonicas y/o sulfuricas de la s-adenosil-l-metionina,particularmente utiles como donadores especificos de metilo para las reacciones bioquimicas de transferencia del grupo ch3;asi como tambien las reacciones fundamentales en el metabolismo lipilico,protilico y glucidico
US4109079A (en) * 1975-10-16 1978-08-22 Yamasa Shoyu Kabushiki Kaisha Stabilized s-adenosyl-l-methionine preparations
GB2064523B (en) * 1979-12-04 1983-06-29 Kanegafuchi Chemical Ind Stable composition of s-adenosyl-l-methionine
IT1137640B (it) * 1981-08-24 1986-09-10 Bioresearch Srl Sali stabili della s-adenosilmetionina,processo per la loro preparazione e composizioni terapeutiche che li comprendono come principio attivo
IT1137892B (it) * 1981-08-24 1986-09-10 Bioresearch Srl Sali stabili della s-adenosilmetionina,processo per la loro preparazione e composizioni terapeutiche che li comprendono come principio attivo
IT1139974B (it) * 1981-09-11 1986-09-24 Bioresearch Srl Derivati della s-adenosilmetionina,processo per la preparazione e composizioni terapeutiche che li contengono come principio attivo
IT1169773B (it) * 1983-08-24 1987-06-03 Bioresearch Spa Processo per la produzione di sali stabili della solfo-adenosil-l-metionina
IT1169774B (it) * 1983-08-24 1987-06-03 Bioresearch Spa Composizioni terapeutiche iniettabili contenenti sali stabili della s-adenosil-l-metionina
IT1173992B (it) * 1984-05-16 1987-06-24 Bioresearch Spa Sali stabili della solfo-adenosil-l-metionina (same) particolarmente idonei per uso farmaceutico orale
IT1173990B (it) * 1984-05-16 1987-06-24 Bioresearch Spa Sali stabili della solfo-adenosil-l-metionina (same) particolarmente adatti per uso parenterale
IT1200589B (it) * 1985-02-14 1989-01-27 Gibipharma Spa Derivati naturali attivita farmagologica
AU2538588A (en) * 1987-10-09 1989-05-02 Mario De Rosa Lipophilic salts of s-adenosyl-l-methionine (sam) with acylated taurine derivatives
DE19515275A1 (de) * 1995-04-26 1996-10-31 Knoll Ag Neue Verwendung von (S)-Adenosyl-L-methionin(SAMe)
US6759395B2 (en) 2000-12-18 2004-07-06 Orchid Chemicals & Pharmaceuticals, Ltd. Soft-gelatin capsule comprising S-adenosylmethionine and a method for producing the same
US8063024B2 (en) * 2005-01-26 2011-11-22 University Of Manitoba Use of S-adenosylmethionine, vitamin E, and vitamin C for the treatment of oxidative liver injury and insulin resistance
US20090012036A1 (en) * 2005-05-24 2009-01-08 Hebert Rolland F Stable S-adenosyl-L-methionine
ITMI20060629A1 (it) * 2006-03-31 2007-10-01 Daniele Giovannone Composizioni solide orali a base di s-adenosilmetionina e processo per il loro ottenimento
US20080206333A1 (en) * 2007-01-31 2008-08-28 Methylation Sciences International Srl Extended Release Pharmaceutical Formulations of S-Adenosylmethionine
US20090088404A1 (en) * 2007-01-31 2009-04-02 Methylation Sciences International Srl Extended Release Pharmaceutical Formulations of S-Adenosylmethionine
US20090197824A1 (en) * 2008-01-31 2009-08-06 Methylation Sciences International Srl Extended Release Pharmaceutical Formulations of S-Adenosylmethionine
ITMI20071374A1 (it) * 2007-07-10 2009-01-11 Gnosis Spa Sali stabili di s-adenosilmetionina e processo per il loro ottenimento.
US20100004191A1 (en) * 2008-07-01 2010-01-07 Rolland F Hebert Compositions of S-adenosyl-L-methionine.
US20110027342A1 (en) 2009-07-28 2011-02-03 Msi Methylation Sciences, Inc. S-adenosylmethionine formulations with enhanced bioavailability
US8329208B2 (en) * 2009-07-28 2012-12-11 Methylation Sciences International Srl Pharmacokinetics of S-adenosylmethionine formulations
US20140187509A1 (en) * 2011-04-15 2014-07-03 Scimar Ltd. Use of s-adenosylmethionine, vitamin e, and vitamin c for the prevention and treatment of cardiovascular dysfunction
IN2015DN04151A (ro) 2012-10-17 2015-10-16 Methylation Sciences Internat Srl
ES2824807T3 (es) 2013-01-16 2021-05-13 Hebert Sam E Llc Sales de indol-3-propionato estables de S-adenosil-L-metionina

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2946781A (en) * 1957-02-06 1960-07-26 Merck & Co Inc Process for the preparation of adenosyl homocysteine
US3642772A (en) * 1968-09-04 1972-02-15 Boehringer Mannheim Gmbh Process for preparing s-adenosyl homocysteine

Also Published As

Publication number Publication date
SU646915A3 (ru) 1979-02-05
US3893999A (en) 1975-07-08
PL87381B1 (ro) 1976-06-30
IL42764A0 (en) 1974-01-14
NL152864B (nl) 1977-04-15
AT341684B (de) 1978-02-27
DD107461A5 (ro) 1974-08-05
JPS4992215A (ro) 1974-09-03
JPS5235726B2 (ro) 1977-09-10
SE400085B (sv) 1978-03-13
GB1425384A (en) 1976-02-18
DE2336401B2 (de) 1979-07-12
DK131868B (da) 1975-09-15
DE2336401A1 (de) 1974-02-14
IE37913B1 (en) 1977-11-09
YU36037B (en) 1981-11-13
ES417377A1 (es) 1976-02-16
NO137941C (no) 1978-05-31
CS195254B2 (en) 1980-01-31
IL42764A (en) 1976-04-30
BE802981A (fr) 1973-11-16
NO137941B (no) 1978-02-13
HU167266B (ro) 1975-09-27
FR2194425B1 (ro) 1976-04-09
AU474015B2 (en) 1976-07-08
FI52466B (ro) 1977-05-31
FR2194425A1 (ro) 1974-03-01
DK131868C (da) 1976-03-08
RO63451A (fr) 1978-07-15
HK31580A (en) 1980-06-20
AR195350A1 (es) 1973-09-28
FI52466C (fi) 1977-09-12
CH592112A5 (ro) 1977-10-14
YU203073A (en) 1981-04-30
NL7310706A (ro) 1974-02-05
DE2336401C3 (de) 1980-03-13
MX4544E (es) 1982-06-08
ATA664173A (de) 1977-06-15
AU5868073A (en) 1975-01-30
IE37913L (en) 1974-02-02
CA1006872A (en) 1977-03-15

Similar Documents

Publication Publication Date Title
ZA734876B (en) Enzymatic salt,the process for its preparation and therapeutical compositions which contain it
CA979893A (en) Substituted indole compound, process for the preparation and therapeutic compositions containing it
CA1007659A (en) Process for the preparation of 3,4,5-trimethoxybenzaldehyde
CA1002532A (en) Process for the preparation of thiamphenicol glycinate
EG10850A (en) Process for the preparation of 1-hydroxy-pyridones
ZA737697B (en) Process for the preparation of thiazolesulphenamides
CA998321A (en) Metal treating compositions
AU471441B2 (en) Process for the preparation of 2-hydrazino-benzothiazoles
AU477038B2 (en) Process for the preparation of alpha-6-deoxytetracyclines
AU474746B2 (en) Process for the preparation of thiazole-sulphenamides
AU472802B2 (en) Process for the preparation of 3-nitro-4-amino-toluene
GB1405791A (en) Process for the preparation of pyridoindolobenzazepines
CA1027973A (en) Process for the preparation of 1,2-dichloroethane
CA1020851A (en) Metal treating compositions
IE37397L (en) Hand cultivators
CA1002065A (en) Process for the preparation of trifluoroacetyl chloride
CA998677A (en) Process for the preparation of 2-substituted-1,3,4-thiadiazole-5-thiols
CA913451A (en) Process for the manufacture of fish soup concentrate
CA936177A (en) Process for the preparation of propionaldehyde
KR780000152B1 (en) Process for the preparation of 2-amino-benzylamines
ZA73926B (en) Process for the preparation of 3,4,5-trimethoxybenzaldehyde
CA901481A (en) Compositions for soil treatment
CA915181A (en) Process for the preparation of 2,2'-bis-(1,3,4-thiazoline-5-thione)
CA904862A (en) Process for preparing 7-halo-6-sulfamyl-2-spiro or dialkyl-4-quinazolinones and the compounds obtained thereby
CA1002067A (en) Process for the treatment of dinitriles